GALT
GALECTIN THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$3.50
−3.45%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.05
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.14
- EPS estimate
- -$0.09
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -21.8%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.09 | -$0.14 | Miss -55.56% | — |
| May 15, 2026 | -$0.06 | -$0.08 | Miss -33.33% | — |
| Mar 31, 2026 | -$0.10 | -$0.08 | Beat 20.00% | — |
| Nov 14, 2025 | -$0.11 | -$0.13 | Miss -18.18% | — |
| Aug 14, 2025 | -$0.16 | -$0.12 | Beat 25.00% | — |
| May 15, 2025 | -$0.20 | -$0.15 | Beat 25.00% | — |
| Mar 31, 2025 | -$0.16 | -$0.19 | Miss -18.75% | $36.0K |
| Nov 14, 2024 | -$0.20 | -$0.18 | Beat 10.00% | — |
| May 15, 2024 | -$0.16 | -$0.19 | Miss -18.75% | — |
| Mar 29, 2024 | -$0.16 | -$0.16 | In line | $80.0K |
| Aug 14, 2023 | -$0.21 | -$0.15 | Beat 28.57% | — |
| May 15, 2023 | -$0.21 | -$0.19 | Beat 9.52% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026